Business Description
Monash IVF Group Ltd
ISIN : AU000000MVF3
Total Employee Number:
771Description
Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.78 | |||||
Debt-to-EBITDA | 3.88 | |||||
Interest Coverage | 5.45 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1 | |||||
Beneish M-Score | -2.83 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.2 | |||||
3-Year EBITDA Growth Rate | 14.9 | |||||
3-Year EPS without NRI Growth Rate | 10.8 | |||||
3-Year Book Growth Rate | -2.8 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 1.96 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.82 | |||||
Quick Ratio | 0.62 | |||||
Cash Ratio | 0.15 | |||||
Days Inventory | 115.77 | |||||
Days Sales Outstanding | 32.49 | |||||
Days Payable | 307.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.68 | |||||
3-Year Dividend Growth Rate | 5.9 | |||||
Shareholder Yield % | -13.31 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 89.02 | |||||
Operating Margin % | 11.41 | |||||
Net Margin % | 5.62 | |||||
EBITDA Margin % | 18.9 | |||||
FCF Margin % | 3.73 | |||||
OCF Margin % | 9.67 | |||||
ROE % | 6.06 | |||||
ROA % | 3.01 | |||||
ROIC % | 4.47 | |||||
3-Year ROIIC % | 9.67 | |||||
ROC (Joel Greenblatt) % | 18.3 | |||||
ROCE % | 6.38 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 18.68 | |||||
Forward PE Ratio | 10.53 | |||||
PE Ratio without NRI | 18.68 | |||||
Shiller PE Ratio | 8.96 | |||||
Price-to-Owner-Earnings | 7.98 | |||||
PS Ratio | 1.03 | |||||
PB Ratio | 1.09 | |||||
Price-to-Free-Cash-Flow | 28.4 | |||||
Price-to-Operating-Cash-Flow | 10.6 | |||||
EV-to-EBIT | 16.95 | |||||
EV-to-EBITDA | 9.23 | |||||
EV-to-Revenue | 1.75 | |||||
EV-to-Forward-Revenue | 1.69 | |||||
EV-to-FCF | 46.86 | |||||
Price-to-GF-Value | 0.51 | |||||
Price-to-Projected-FCF | 0.7 | |||||
Price-to-Median-PS-Value | 0.5 | |||||
Earnings Yield (Greenblatt) % | 5.9 | |||||
FCF Yield % | 3.63 | |||||
Forward Rate of Return (Yacktman) % | -0.55 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MNIVF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Monash IVF Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 177.287 | ||
| EPS (TTM) ($) | 0.025 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 21.86 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 0.4 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.4 - 0.4 | ||
| Shares Outstanding (Mil) | 389.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Monash IVF Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Monash IVF Group Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| AUD 0.012000 Cash Dividend | 2026-03-05 | 0.40 (+0.00%) | ||
| AUD 0.026000 Cash Dividend | 2025-03-06 | 0.74 (+0.00%) | ||
| AUD 0.025000 Cash Dividend | 2024-09-05 | -- |
Show
Entries
Monash IVF Group Ltd Frequently Asked Questions
What is Monash IVF Group Ltd(MNIVF)'s stock price today?
The current price of MNIVF is $0.40. The 52 week high of MNIVF is $0.40 and 52 week low is $0.40.
When is next earnings date of Monash IVF Group Ltd(MNIVF)?
The next earnings date of Monash IVF Group Ltd(MNIVF) is .
Does Monash IVF Group Ltd(MNIVF) pay dividends? If so, how much?
Monash IVF Group Ltd(MNIVF) does not pay dividend.
Guru Commentaries on OTCPK:MNIVF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Monash IVF Group Ltd
No articles.